Comparative Pharmacology
Head-to-head clinical analysis: GLYCOLAX versus PLENVU.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GLYCOLAX versus PLENVU.
GLYCOLAX vs PLENVU
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
PLENVU is an osmotic laxative that induces bowel cleansing by causing water retention in the colon, leading to increased intraluminal pressure and stimulation of peristalsis. Its components (polyethylene glycol 3350, sodium ascorbate, ascorbic acid, sodium sulfate) act synergistically to produce a cathartic effect.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
2 sachets (each containing ascorbic acid 4.7g, macrogol 3350 52.5g, sodium ascorbate 5.9g, sodium sulfate 3.75g) dissolved in water to a total volume of 500mL, administered orally as a split-dose regimen: first dose (2 sachets in 500mL water) at 6-9 pm on the day before colonoscopy, followed by additional 500mL of clear fluids; second dose (2 sachets in 500mL water) on the morning of colonoscopy, completed at least 2 hours before the procedure, followed by additional 500mL of clear fluids.
None Documented
None Documented
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
Not applicable (non-absorbed agent); systemic absorption is minimal, so no terminal half-life is defined.
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Primarily fecal (90-95%) as unabsorbed drug; renal excretion is negligible (<1%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative